FEMTECH INDUSTRY IN INTERACTIVE CHARTS

FemTech Market Size, 2020-2025

FemTech Analytics views FemTech as software, diagnostics, products and services that use technology to focus on women's health and wellness. The global FemTech Market Size accounted for $40.2 billion in 2020 and is projected to grow at an average CAGR of 13.3% from 2020 till 2025 to reach $75.1 billion. Despite increasing interest in recent years, the industry remains underestimated and has high growth potential.
The US is the undisputed leader with the highest number of FemTech companies. Accounting for nearly a half of the total number of FemTech companies, it beats other countries by a wide margin. The UK is the second, at 10%, followed by Israel with 6%. 

Top 5 Countries by the Number of FemTech Companies, 2021

1300+ FemTech companies have been classified according to 10 subsectors such as Menstrual Health, Reproductive Health & Contraception, Longevity, Pregnancy & Nursing, General Health Care, Mental Health, Menopause Care, Sexual Health, Pelvic & Uterine Health Care, and Women's Wellness.

Accounting for 21% of the total market, Pregnancy and Nursing is the largest subsector of the FemTech Industry by the number of companies. It is followed by the Reproductive Health and Contraception subsector, which accounts for 17%, and Menstrual Health together with General Health Care, both occupying the third place and 14% each. These top subsectors comprise 65% of the entire FemTech market.

Distribution of FemTech Companies by Subsector, 2021

The FemTech sector primarily addresses women’s health, including consumer products such as innovative femcare, a wide range of devices addressing Sexual Health and Reproductive Health along with software and apps for pregnancy and nursing care, women’s wellness, Longevity, and menstrual health. Products for dealing with menstrual flow – such as reusable absorbent underwear, the reusable cup, and flushable pads – are now competing to provide the safest, most convenient, affordable, and environmentally friendly option to the hundreds of millions of people worldwide who are actively in need of them. 

Distribution of FemTech Companies by Product Type, 2021

As of December 2021, the total funding to the FemTech sector was about $14 billion. The General Health Care subsector (179 companies) leads the market by total fundings of approximately $3.4 billion at the end of 2021. The two other largest subsectors by funding are Reproductive Health and Contraception ($2.7 billion in 217 companies) and Longevity ($2.6 billion having just 31 companies).

Total Funding Amount of FemTech Companies by Subsector, 2021

Many companies have gone through significant improvements and changes during the last few years. The more companies become FemTech-focused, the more investment appears in the industry, and therefore, new players and decision-makers emerge on the global FemTech market. More than $10 billion was invested in US-based companies, as of December 2021. 

Top 10 Countries of FemTech Companies by Total Funding Amount, 2021

Being an important part of the FemTech Industry, FemTech Longevity focuses on technologies, services, and research related to extending women’s healthy lifespan.

Geographically, most FemTech Longevity companies are based in North America, particularly in the US (58% of companies). There is only one company in Canada with a Longevity focus — Endoceutics. Europe is the second-largest region, with a 26% share. The FemTech Longevity subsector somewhat less represents Asian countries, MENA, and Australia. 

Distribution of FemTech Longevity Companies by Major Regions, 2021

The largest number of companies comprising 53% out of total in the FemTech Longevity subsector show revenue, estimated in the range of $1 million to $10 million. The revenue of about 7% of companies does not exceed $1 million, while 20% of players have revenue from $10 million to $50 million.

FemTech Longevity Companies by Estimated Revenue, 2021

Funding of companies in the FemTech Longevity subsector totaled over $2.6 billion in 2021, with 81% falling to the top 10 market players.

 

Invitae, a genetic information company that is aimed to incorporate genetic information into everyday medical practice to boost the quality of healthcare for billions of people, had the largerst funding as of December 2021 at almost $2 billion.

Top 10 FemTech Longevity Companies by Total Funding Amount, 2021

In 2021, the global VC investment in FemTech crossed $1 billion for the first time. 
One of the reasons why the industry is not getting significant VC funding is the poor track record of sizable exits. 
Unfortunately, it is still comparatively low levels of investment in FemTech, which represent a fundamental challenge across the sector. 

Global VC Investment in FemTech, 2012-2021

Accounting for nearly 65%, the US has a leading number of FemTech investors (in FemTech focused companies).

Top 10 Countries by Share of FemTech Investors, 2021

Selected of the major deals in Q4 2021 included:
- Evofem — $444.2 million, biotechnology company that develops reproductive and contraceptive care products for women worldwide (Post-IPO Equity)
- Progenity — $248.5 million, clinical laboratory services to provide physicians and patients with accurate, timely and state-of-the-art test results (Post-IPO Equity)
- Agile Therapeutics — $204.5 million, pharmaceutical company developing contraceptive health care products for women (Post-IPO Equity)
- Elvie — $151.9 million, a British FemTech company developing smart technology for women (Series C round)
- The Mom Project — $80 million, a digital talent marketplace helping women remain active in the workforce (Series C round)

Top 5 Investment Deals in FemTech in Q4 2021

The interactive chart below illustrates 10 leading publicly traded companies in FemTech by the capitalization in 2021.

As of December 8, 2021, the total market capitalization of 28 FemTech publicly traded companies was almost $70 billion. The Pregnancy & Nursing subsector is the largest public sector accounting for 68% of total market capitalization.

With a market capitalization of $47.3 billion, Pulsenmore was the largest company.

Top 10 Publicly Traded Companies by Capitalization, 2021